Skip to content

Esketamine and dexmedetomidine on myocardial injury after major noncardiac surgery in elderly patients with planned ICU admission: a randomized controlled study

Esketamine and dexmedetomidine on myocardial injury after major noncardiac surgery in elderly patients with planned ICU admission: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081072
Enrollment
Unknown
Registered
2024-02-21
Start date
2024-02-23
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative myocardial injury

Interventions

Esketamine group:Esketamine
Dexmedetomidine group:Dexmedetomidine
Control group:Normal saline

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Age = 60 years old, male or female; 2) Undergoing major non-cardiac surgery, with an estimated surgical time = 2 hours and planned ICU admission after operation; 3) Have a clear understanding of the experimental process and voluntarily participate, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Sick sinus syndrome, second degree or higher atrioventricular block without a pacemaker, severe cardiac insufficiency (LVEF < 30%), severe liver insufficiency (Chil-Pugh C), and renal failure; 2) Patients with poor or untreated hypertension control (At rest, SBP greater than 180 mmHg and/or DBP greater than 100 mmHg ); 3) Unstable angina, increased intracranial pressure, intracranial aneurysms; 4) Hypersensitivity to esketamine or dexmedetomidine;

Design outcomes

Primary

MeasureTime frame
Incidence of MINS after surgery;

Secondary

MeasureTime frame
Postoperative elevation of cTnI;Other postoperative myocardial enzyme spectrum indicators;Quality of postoperative recovery;NRS pain score at rest and during activity at 24 and 48 hours after surgery;Complications and adverse events;Postoperative hospital stay;Postoperative 30-day mortality;Postoperative sleep quality;

Countries

China

Contacts

Public ContactPeng Ke

Department of Anesthesiology, The First Affiliated Hospital of Soochow University

pengke@suda.edu.cn+86 159 6215 5989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026